Trials / Completed
CompletedNCT02406612
X-Seal EU Post-Market Clinical Follow-Up Protocol
X-Seal 6F Vascular Closure Device EU Post-Market Clinical Follow-Up Protocol
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- Essential Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to prospectively collect data on and confirm the safety and effectiveness of the X-Seal 6F Vascular Closure System in reducing time to hemostasis and time to ambulation for patients who have undergone diagnostic or interventional catheterization procedures using up to 6F sheaths when compared with standard compression techniques using data from literature surveys.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | X-Seal 6F Vascular Closure Device |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2016-02-01
- Completion
- 2016-06-01
- First posted
- 2015-04-02
- Last updated
- 2018-10-29
- Results posted
- 2018-10-29
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02406612. Inclusion in this directory is not an endorsement.